Non-Inferiority Study of GSK Biologicals' Pandemic Influenza Vaccine 1562902A.
Phase of Trial: Phase III
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary) ; AS03A
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 23 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Dec 2008 New trial record.